Sign in with Google. Opens in new tab
ENTITY
Biocon Ltd

Biocon Ltd (BIOS IN)

138
Analysis
Health CareIndia
Biocon Ltd., is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immunosuppressants and anti-diabetic drugs. Biocon also manufactures specialty enzymes and new enzyme applications besides providing clinical and custom research services.
more
19 Jan 2025 00:30

APAC Healthcare Weekly (Jan 19)- Samsung Biologics, Daiichi Sankyo, Eisai, Sun Pharma, Biocon

APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...

Logo
458 Views
Share
bullishCelltrion Inc
13 Dec 2024 09:09

Celltrion Inc (068270 KS): Record High Sales in 3Q; Pipeline Progress Entails Long-Term Growth

Celltrion has announced dividend of KRW750 per share and one bonus shares for every 20 shares held. The record date for dividend payment and bonus...

Logo
725 Views
Share
bullishCIFI Holdings
28 Oct 2024 12:40

Lucror Analytics - Morning Views Asia

In the US, the September preliminary durable goods orders fell 0.8% m-o-m (-1.0% e / -0.8% revised p), mainly driven by a decline in bookings for...

Logo
234 Views
Share
26 Oct 2024 23:30

APAC Healthcare Weekly (Oct 27)- Samsung Biologics, Celltrion, Astellas, Otsuka, Legend, and Zai Lab

Samsung Biologics secures largest ever contract, Celltrion announced KRW100B buyback, Astellas Pharma got label expansion approval for Vyloy,...

Logo
591 Views
Share
bullishSK Hynix
25 Oct 2024 06:30

Weekly Wrap - 25 Oct 2024

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and...

Logo
547 Views
Share
x